About Us
Get Support: 1300 884 450
Make a Donation
About Melanoma
Patient Resources
Support
Get Involved
News & Events
Contact Us
0
items in cart
Search
Close menu
Get Involved
National Melanoma Support Line:
1300 884 450
Get Involved
Donate
Advocacy
Spotlight on Melanoma
Community Involvement
Partner With Us
Melanoma Movement
Fundraising
How To Fundraise
Fundraising Rules
MPA’s Fundraisers
Volunteers
Online Portal
MPA/MIA Community Webinar Series
Read more
Close menu
Support
National Melanoma Support Line:
1300 884 450
Patient Stories
Patient Stories Blog
Share Your Story
Support Services
Information & Support Centre
Melanoma Nurse Telehealth Service
Support Groups
One-on-One Peer Support
Wellness Hub
Health Check Ups & Monitoring
Strategies To Build Resilience
Eating Well
Exercise
Mindfulness & Relaxation
Financial Wellbeing
Wellness Resources
Close menu
Patient Resources
National Melanoma Support Line:
1300 884 450
Staging Of Melanoma
Stage 0 (In Situ)
Stage 1
Stage 2
Stage 3
Stage 4
Diagnosis
How Is Melanoma Diagnosed?
Just Been Diagnosed With Melanoma?
Diagnostic Tests & Scans
Treatment
Treatment Of Melanoma
Treatment Centres
Concerns During & After Treatment
Managing Side Effects
Complimentary Therapies
Clinical Trials
Patient Resources
Melanoma Myths
MPA Resources
Close menu
About Melanoma
National Melanoma Support Line:
1300 884 450
Preventing Melanoma
Risk Factors
Prevention
Early Detection
What Is Melanoma?
What Is Melanoma
Types Of Melanoma
Melanoma Facts
Mutations In Melanoma
Glossary
MPA/MIA Community Webinar Series
Read more
Close search
Search
Search
Go
Suggestions
Patient Stories
Stages of Melanoma
Healthcare professionals
Early detection
Prevention
Get Involved
Donate
Advocacy
Spotlight on Melanoma
Community Involvement
Partner With Us
Melanoma Movement
Melanoma Advocate Form
Register today to become a melanoma advocate!
Name
(Required)
First
Last
Email
(Required)
Phone number
(Required)
Location
(Required)
State / Province / Region
ZIP / Postal Code
Country
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czechia
Côte d'Ivoire
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine, State of
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Romania
Russian Federation
Rwanda
Réunion
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Sweden
Switzerland
Syria Arab Republic
Taiwan
Tajikistan
Tanzania, the United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkmenistan
Turks and Caicos Islands
Tuvalu
Türkiye
US Minor Outlying Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Åland Islands
What type of Melanoma Advocate are you?
(Required)
Melanoma Patient
Family Member
Friend
Carer
Other
What Melanoma Stage are you?
Stage 0 (in situ)
Stage I
Stage II
Stage III
Stage IV
What treatment have you had for Melanoma
(Required)
Surgery
Targeted Therapy
Immunotherapy
Adjuvant Treatment
Radiotherapy
Clinical Trial
MPA needs passionate Melanoma Advocates to do the following roles. Which of these roles interest you?
Local media spokespeople
Speakers at events
Advocates with politicians
Survey and advisory group participants
Share your story to help others
Spread the word and raise awareness in your community
Other
Other
About Melanoma
Patient Resources
Support
Get Involved
News & Events
Contact Us
About Us
Get Support: 1300 884 450
Make a Donation
